D'ANNA, STEFANO
D'ANNA, STEFANO
Dipartimento di Biologia
A high degree of genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity.
2025-01-01 Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V
An increased genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity
2025-01-01 Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V
Caratterizzazione intraepatica dell'attività di HDV sostenuta dall'integrazione di HBV al baseline e sotto trattamento.
2025-01-01 Grossi, I; D'Anna, S; Di Lorenzo, A; Piermatteo, L; Ceccherini Silberstein, F; Sarmati, L; Salpini, R; Svicher, V
Chronic HDV infection is sustained by an intense HBsAg production fromintegrated HBVDNA in the setting of a limited or even absent HBV reservoir.
2024-01-01 Salpini, 1r; D'Anna, S; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, A; Abate, Ml; Olivero, A; Gaeta, G; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher., V
Comparison of diagnostic performances of HDV-RNA quantification assays used in clinical practice: Results from a national quality control multicenter study
2025-10-01 Salpini, R; Piermatteo, L; Caviglia, Gp; Bertoli, A; Brunetto, Mr; Bruzzone, B; Callegaro, A; Caudai, C; Cavallone, D; Chessa, L; Coghe, F; Coppola, N; Cuomo, N; D'Anna, S; Di Stefano, M; Facchetti, F; Farina, C; Ferraro, D; Franchin, E; Francisci, D; Galli, S; Garbuglia, Ar; Gennari, W; Ghisetti, V; Lampertico, P; Lo Caputo, S; Marascio, N; Menzo, S; Micheli, V; Niro, Ga; Olivero, A; Paba, P; Palermo, Ci; Palmieri, O; Paolucci, S; Pisaturo, M; Pollicino, T; Raffa, G; Santantonio, T; Torre, G; Turriziani, O; Uzzau, S; Uceda Renteria, Sc; Vatteroni, M; Zazzi, M; Craxì, A; Ceccherini-Silberstein, F; Svicher, V; Arosio, M; Bastianelli, S; Gentile, A; Giardina, Fam; Gidari, A; Govoni, R; Ibba, G; Loglio, A; Lombardi, A; Mascarella, C; Maggi, F; Matera, G; Mazzei, C; Milia, Mg; Quirino, A; Raddi, A; Scioscia, R; Tagliazucchi, S; Totaro, M; Valaperta, R
Comprehensive insight of epidemiological and virological features underlying patients with HBV/HDV co-infection drug-naïve or treated with the recently approved entry inhibitor
2023-01-01 D'Anna, S
Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort
2024-02-01 d'Arminio Monforte, A; Tavelli, A; Salpini, R; Piermatteo, L; D'Anna, S; Carrara, S; Malagnino, V; Mazzotta, V; Brancaccio, G; Marchetti, Gc; Rosselli Del Turco, E; Rossotti, R; Mussini, C; Antinori, A; Lo Caputo, S; Ceccherini Silberstein, F; Gaeta, Gb; Svicher, V; Puoti, M
Different diagnostic performances of HDV RNA quantification assays used in clinical practicein Italy: results from a national quality control multicenter study.
2024-01-01 Salpini, 7r; Piermatteo, L; Caviglia, Gp; Bertoli, A; Brunetto, Mr; Bruzzone, B; Callegaro, A; Caudai, C; Cavallone, D; Chessa, L; Coghe, F; Coppola, N; Cuomo, N; D'Anna, S; Di Stefano, M; Duca, L; Facchetti, F; Farina, C; Ferraro, D; Franchin, E; Francisci, D; Galli, S; Garbuglia, Ar; Gennari, W; Ghisetti, V; Lampertico, P; Marascio, N; Menzo, S; Micheli, V; Niro, G; Olivero, A; Paba, P; Palermo, Ci; Palmieri, O; Paolucci, S; Pisaturo, M; Pollicino, T; Raffa, G; Torre, G; Turriziani, O; Uzzau, S; Vatteroni, M; Zazzi, M; Craxì, A; Ceccherini-Silberstein, F; Svicher On Behalf Of The Virology Italian Network Vironet C., V
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing
2023-01-01 Bellocchi, Mc; Scutari, R; Carioti, L; Iannetta, M; Marchegiani, G; Piermatteo, L; Coppola, L; Tedde, S; Duca, L; Malagnino, V; Ansaldo, L; Braccialarghe, N; D′Anna, S; Mercedes Santoro, M; DI LORENZO, A; Salpini, R; Teti, E; Svicher, V; Andreoni, M; Sarmati, L; Ceccherini-Silberstein, F
HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation
2021-01-01 Piermatteo, L; Alkhatib, M; D’Anna, S; Malagnino, V; Bertoli, A; Andreassi, E; Basile, E; Iuvara, A; Maria De Cristofaro, ; Cappiello, G; Cerva, C; Minichini, C; Pisaturo, M; Starace, M; Coppola, N; Fontana, C; Grelli, S; Ceccherini-Silberstein, F; Andreoni, M; Gill, Us; Kennedy, Ptf; Sarmati, L; Salpini, R; Svicher, V
HBsAg Isoforms as Innovative Biomarkers in Predicting Virological Response to Bulevirtide in Patients With Chronic Hepatitis D
2025-05-01 D'Anna, S; Salpini, R; Degasperi, E; Piermatteo, L; Facchetti, F; Sambarino, D; Torre, G; Borghi, M; Anolli, Mp; Monico, S; Svicher, V; Lampertico, P
HBV integration can sustain intrahepatic HDV activity and can modulate HBV pathogenetic potential.
2025-01-01 D'Anna, S; Piermatteo, L; Di Lorenzo, A; Carioti, L; Brancaccio, G; Teti, E; Grossi, I; Castelli, C; Magnapera, A; Malagnino, V; Iannetta, M; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R
HDV persistence acts independently from HBV reservoir extent and is sustained by HBsAg production mainly derived from integrated HBV-DNA
2025-01-01 D'Anna, S; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R
HDV sub-genotype 1 is characterized by increased genetic variability, which can promote the emergence of divergent genetic pathways that modulate HDV replicative potential and cytolytic activity.
2025-01-01 Magnapera, A; Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Gaeta, Gb; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V
Hepatitis delta virus (HDV) infection : frequency and outcome in persons living with HIV (PLWH). Data from the ICONA (Italian cohort of naïve for antiretrovirals) cohort
2023-01-01 Puoti, M; Salpini, R; Tavelli, A; Piermatteo, L; D’Anna, S; Carrara, S; Malagnino, V; Mazzotta, V; Brancaccio, G; Battista Gaeta, G; Marchetti, G; Viale, P; Perno, C; Svicher, V; D’Arminio Monforte, A
Heterogeneity in the diagnostic performances of HDV RNA quantification assays used in clinical practice in Italy: results from a national quality control multicenter study.
2024-01-01 Salpini, 1r; Piermatteo, L; Caviglia, Gp; Bertoli, A; Brunetto, Mr; Bruzzone, B; Callegaro, A; Caudai, C; Cavallone, D; Chessa, L; Coghe, F; Coppola, N; Cuomo, N; D'Anna, S; Di Stefano, M; Duca, L; Facchetti, F; Farina, C; Ferraro, D; Franchin, E; Francisci, D; Galli, S; Garbuglia, Ar; Gennari, W; Ghisetti, V; Lampertico, P; Marascio, N; Menzo, S; Micheli, V; Niro, G; Olivero, A; Paba, P; Palermo, Ci; Palmieri, O; Paolucci, S; Pisaturo, M; Pollicino, T; Raffa, G; Torre, G; Turriziani, O; Uzzau, S; Vatteroni, M; Zazzi, M; Craxì, A; Ceccherini-Silberstein, F; Svicher On Behalf Of The Virology Italian Network Vironet C., V
Heterogeneity in the diagnostic sensitivities of HDV RNA quantification assays used in clinical practice in Italy: data from the first national quality control multicenter study.
2024-01-01 Salpini, 1r; Piermatteo, L; Caviglia, Gp; Bertoli, A; Brunetto, Mr; Bruzzone, B; Callegaro, A; Caudai, C; Cavallone, D; Chessa, L; Coghe, F; Coppola, N; Cuomo, N; D'Anna, S; Di Stefano, M; Duca, L; Facchetti, F; Farina, C; Ferraro, D; Franchin, E; Francisci, D; Galli, S; Garbuglia, Ar; Gennari, W; Ghisetti, V; Lampertico, P; Marascio, N; Menzo, S; Micheli, V; Niro, G; Olivero, A; Paba, P; Palermo, Ci; Palmieri, O; Paolucci, S; Pisaturo, M; Pollicino, T; Raffa, G; Torre, G; Turriziani, O; Uzzau, S; Vatteroni, M; Zazzi, M; Craxì, A; Ceccherini-Silberstein, F; Svicher On Behalf Of The Virology Italian Network Vironet C, V
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage.
2023-01-01 Duca, L; Olivero, A; Piermatteo, L; D’Anna, S; Torre, G; Teti, E; DI LORENZO, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; CECCHERINI SILBERSTEIN, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Rizzetto, M; Paolo Caviglia, G; Svicher, V; Salpini, R
HIV/HBV coinfection remodels the immune landscape and natural killer cell ADCC functional responses
2024-09-01 Sun, B; da Costa, Kas; Alrubayyi, A; Kokici, J; Fisher-Pearson, N; Hussain, N; D'Anna, S; Piermatteo, L; Salpini, R; Svicher, V; Kucykowicz, S; Ghosh, I; Burns, F; Kinloch, S; Simoes, P; Bhagani, S; Kennedy, Ptf; Maini, Mk; Bashford-Rogers, R; Gill, Us; Peppa, D
Insights into the Currently Available Drugs and Investigational Compounds Against RSV with a Focus on Their Drug-Resistance Profiles
2025-05-30 Magnapera, A; Riccio, A; Curcio, A; Tramontozzi, C; Piermatteo, L; D'Anna, S; Alcaro, S; Alteri, C; La Frazia, S; Artese, A; Salpini, R; Svicher, V
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2025 | A high degree of genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity. | Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V | Intervento a convegno | |
| 1-gen-2025 | An increased genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity | Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V | Intervento a convegno | |
| 1-gen-2025 | Caratterizzazione intraepatica dell'attività di HDV sostenuta dall'integrazione di HBV al baseline e sotto trattamento. | Grossi, I; D'Anna, S; Di Lorenzo, A; Piermatteo, L; Ceccherini Silberstein, F; Sarmati, L; Salpini, R; Svicher, V | Intervento a convegno | |
| 1-gen-2024 | Chronic HDV infection is sustained by an intense HBsAg production fromintegrated HBVDNA in the setting of a limited or even absent HBV reservoir. | Salpini, 1r; D'Anna, S; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, A; Abate, Ml; Olivero, A; Gaeta, G; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher., V | Intervento a convegno | |
| 1-ott-2025 | Comparison of diagnostic performances of HDV-RNA quantification assays used in clinical practice: Results from a national quality control multicenter study | Salpini, R; Piermatteo, L; Caviglia, Gp; Bertoli, A; Brunetto, Mr; Bruzzone, B; Callegaro, A; Caudai, C; Cavallone, D; Chessa, L; Coghe, F; Coppola, N; Cuomo, N; D'Anna, S; Di Stefano, M; Facchetti, F; Farina, C; Ferraro, D; Franchin, E; Francisci, D; Galli, S; Garbuglia, Ar; Gennari, W; Ghisetti, V; Lampertico, P; Lo Caputo, S; Marascio, N; Menzo, S; Micheli, V; Niro, Ga; Olivero, A; Paba, P; Palermo, Ci; Palmieri, O; Paolucci, S; Pisaturo, M; Pollicino, T; Raffa, G; Santantonio, T; Torre, G; Turriziani, O; Uzzau, S; Uceda Renteria, Sc; Vatteroni, M; Zazzi, M; Craxì, A; Ceccherini-Silberstein, F; Svicher, V; Arosio, M; Bastianelli, S; Gentile, A; Giardina, Fam; Gidari, A; Govoni, R; Ibba, G; Loglio, A; Lombardi, A; Mascarella, C; Maggi, F; Matera, G; Mazzei, C; Milia, Mg; Quirino, A; Raddi, A; Scioscia, R; Tagliazucchi, S; Totaro, M; Valaperta, R | Articolo su rivista | |
| 1-gen-2023 | Comprehensive insight of epidemiological and virological features underlying patients with HBV/HDV co-infection drug-naïve or treated with the recently approved entry inhibitor | D'Anna, S | Tesi di dottorato | |
| 1-feb-2024 | Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort | d'Arminio Monforte, A; Tavelli, A; Salpini, R; Piermatteo, L; D'Anna, S; Carrara, S; Malagnino, V; Mazzotta, V; Brancaccio, G; Marchetti, Gc; Rosselli Del Turco, E; Rossotti, R; Mussini, C; Antinori, A; Lo Caputo, S; Ceccherini Silberstein, F; Gaeta, Gb; Svicher, V; Puoti, M | Articolo su rivista | |
| 1-gen-2024 | Different diagnostic performances of HDV RNA quantification assays used in clinical practicein Italy: results from a national quality control multicenter study. | Salpini, 7r; Piermatteo, L; Caviglia, Gp; Bertoli, A; Brunetto, Mr; Bruzzone, B; Callegaro, A; Caudai, C; Cavallone, D; Chessa, L; Coghe, F; Coppola, N; Cuomo, N; D'Anna, S; Di Stefano, M; Duca, L; Facchetti, F; Farina, C; Ferraro, D; Franchin, E; Francisci, D; Galli, S; Garbuglia, Ar; Gennari, W; Ghisetti, V; Lampertico, P; Marascio, N; Menzo, S; Micheli, V; Niro, G; Olivero, A; Paba, P; Palermo, Ci; Palmieri, O; Paolucci, S; Pisaturo, M; Pollicino, T; Raffa, G; Torre, G; Turriziani, O; Uzzau, S; Vatteroni, M; Zazzi, M; Craxì, A; Ceccherini-Silberstein, F; Svicher On Behalf Of The Virology Italian Network Vironet C., V | Intervento a convegno | |
| 1-gen-2023 | Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing | Bellocchi, Mc; Scutari, R; Carioti, L; Iannetta, M; Marchegiani, G; Piermatteo, L; Coppola, L; Tedde, S; Duca, L; Malagnino, V; Ansaldo, L; Braccialarghe, N; D′Anna, S; Mercedes Santoro, M; DI LORENZO, A; Salpini, R; Teti, E; Svicher, V; Andreoni, M; Sarmati, L; Ceccherini-Silberstein, F | Articolo su rivista | |
| 1-gen-2021 | HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation | Piermatteo, L; Alkhatib, M; D’Anna, S; Malagnino, V; Bertoli, A; Andreassi, E; Basile, E; Iuvara, A; Maria De Cristofaro, ; Cappiello, G; Cerva, C; Minichini, C; Pisaturo, M; Starace, M; Coppola, N; Fontana, C; Grelli, S; Ceccherini-Silberstein, F; Andreoni, M; Gill, Us; Kennedy, Ptf; Sarmati, L; Salpini, R; Svicher, V | Articolo su rivista | |
| 1-mag-2025 | HBsAg Isoforms as Innovative Biomarkers in Predicting Virological Response to Bulevirtide in Patients With Chronic Hepatitis D | D'Anna, S; Salpini, R; Degasperi, E; Piermatteo, L; Facchetti, F; Sambarino, D; Torre, G; Borghi, M; Anolli, Mp; Monico, S; Svicher, V; Lampertico, P | Articolo su rivista | |
| 1-gen-2025 | HBV integration can sustain intrahepatic HDV activity and can modulate HBV pathogenetic potential. | D'Anna, S; Piermatteo, L; Di Lorenzo, A; Carioti, L; Brancaccio, G; Teti, E; Grossi, I; Castelli, C; Magnapera, A; Malagnino, V; Iannetta, M; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2025 | HDV persistence acts independently from HBV reservoir extent and is sustained by HBsAg production mainly derived from integrated HBV-DNA | D'Anna, S; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2025 | HDV sub-genotype 1 is characterized by increased genetic variability, which can promote the emergence of divergent genetic pathways that modulate HDV replicative potential and cytolytic activity. | Magnapera, A; Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Gaeta, Gb; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V | Intervento a convegno | |
| 1-gen-2023 | Hepatitis delta virus (HDV) infection : frequency and outcome in persons living with HIV (PLWH). Data from the ICONA (Italian cohort of naïve for antiretrovirals) cohort | Puoti, M; Salpini, R; Tavelli, A; Piermatteo, L; D’Anna, S; Carrara, S; Malagnino, V; Mazzotta, V; Brancaccio, G; Battista Gaeta, G; Marchetti, G; Viale, P; Perno, C; Svicher, V; D’Arminio Monforte, A | Intervento a convegno | |
| 1-gen-2024 | Heterogeneity in the diagnostic performances of HDV RNA quantification assays used in clinical practice in Italy: results from a national quality control multicenter study. | Salpini, 1r; Piermatteo, L; Caviglia, Gp; Bertoli, A; Brunetto, Mr; Bruzzone, B; Callegaro, A; Caudai, C; Cavallone, D; Chessa, L; Coghe, F; Coppola, N; Cuomo, N; D'Anna, S; Di Stefano, M; Duca, L; Facchetti, F; Farina, C; Ferraro, D; Franchin, E; Francisci, D; Galli, S; Garbuglia, Ar; Gennari, W; Ghisetti, V; Lampertico, P; Marascio, N; Menzo, S; Micheli, V; Niro, G; Olivero, A; Paba, P; Palermo, Ci; Palmieri, O; Paolucci, S; Pisaturo, M; Pollicino, T; Raffa, G; Torre, G; Turriziani, O; Uzzau, S; Vatteroni, M; Zazzi, M; Craxì, A; Ceccherini-Silberstein, F; Svicher On Behalf Of The Virology Italian Network Vironet C., V | Intervento a convegno | |
| 1-gen-2024 | Heterogeneity in the diagnostic sensitivities of HDV RNA quantification assays used in clinical practice in Italy: data from the first national quality control multicenter study. | Salpini, 1r; Piermatteo, L; Caviglia, Gp; Bertoli, A; Brunetto, Mr; Bruzzone, B; Callegaro, A; Caudai, C; Cavallone, D; Chessa, L; Coghe, F; Coppola, N; Cuomo, N; D'Anna, S; Di Stefano, M; Duca, L; Facchetti, F; Farina, C; Ferraro, D; Franchin, E; Francisci, D; Galli, S; Garbuglia, Ar; Gennari, W; Ghisetti, V; Lampertico, P; Marascio, N; Menzo, S; Micheli, V; Niro, G; Olivero, A; Paba, P; Palermo, Ci; Palmieri, O; Paolucci, S; Pisaturo, M; Pollicino, T; Raffa, G; Torre, G; Turriziani, O; Uzzau, S; Vatteroni, M; Zazzi, M; Craxì, A; Ceccherini-Silberstein, F; Svicher On Behalf Of The Virology Italian Network Vironet C, V | Intervento a convegno | |
| 1-gen-2023 | Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. | Duca, L; Olivero, A; Piermatteo, L; D’Anna, S; Torre, G; Teti, E; DI LORENZO, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; CECCHERINI SILBERSTEIN, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Rizzetto, M; Paolo Caviglia, G; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-set-2024 | HIV/HBV coinfection remodels the immune landscape and natural killer cell ADCC functional responses | Sun, B; da Costa, Kas; Alrubayyi, A; Kokici, J; Fisher-Pearson, N; Hussain, N; D'Anna, S; Piermatteo, L; Salpini, R; Svicher, V; Kucykowicz, S; Ghosh, I; Burns, F; Kinloch, S; Simoes, P; Bhagani, S; Kennedy, Ptf; Maini, Mk; Bashford-Rogers, R; Gill, Us; Peppa, D | Articolo su rivista | |
| 30-mag-2025 | Insights into the Currently Available Drugs and Investigational Compounds Against RSV with a Focus on Their Drug-Resistance Profiles | Magnapera, A; Riccio, A; Curcio, A; Tramontozzi, C; Piermatteo, L; D'Anna, S; Alcaro, S; Alteri, C; La Frazia, S; Artese, A; Salpini, R; Svicher, V | Articolo su rivista |